| Year |
Citation |
Score |
| 2016 |
Bagalkot V, Deiuliis JA, Rajagopalan S, Maiseyeu A. "Eat me" imaging and therapy. Advanced Drug Delivery Reviews. PMID 26826436 DOI: 10.1016/J.Addr.2016.01.009 |
0.517 |
|
| 2015 |
Bagalkot V, Badgeley MA, Kampfrath T, Deiuliis JA, Rajagopalan S, Maiseyeu A. Hybrid nanoparticles improve targeting to inflammatory macrophages through phagocytic signals. Journal of Controlled Release : Official Journal of the Controlled Release Society. 217: 243-55. PMID 26386437 DOI: 10.1016/J.Jconrel.2015.09.027 |
0.496 |
|
| 2014 |
Maiseyeu A, Bagalkot V. In vitro uptake of apoptotic body mimicking phosphatidylserine-quantum dot micelles by monocytic cell line. Nanoscale Research Letters. 9: 176. PMID 24725273 DOI: 10.1186/1556-276X-9-176 |
0.364 |
|
| 2013 |
Probst CE, Zrazhevskiy P, Bagalkot V, Gao X. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Advanced Drug Delivery Reviews. 65: 703-18. PMID 23000745 DOI: 10.1016/J.Addr.2012.09.036 |
0.412 |
|
| 2011 |
Bagalkot V, Gao X. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing. Acs Nano. 5: 8131-9. PMID 21936502 DOI: 10.1021/Nn202772P |
0.597 |
|
| 2009 |
Bagalkot V, Lee IH, Yu MK, Lee E, Park S, Lee JH, Jon S. A combined chemoimmunotherapy approach using a plasmid-doxorubicin complex. Molecular Pharmaceutics. 6: 1019-28. PMID 19338265 DOI: 10.1021/Mp800177F |
0.315 |
|
| 2008 |
Wang AZ, Bagalkot V, Vasilliou CC, Gu F, Alexis F, Zhang L, Shaikh M, Yuet K, Cima MJ, Langer R, Kantoff PW, Bander NH, Jon S, Farokhzad OC. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. Chemmedchem. 3: 1311-5. PMID 18613203 DOI: 10.1002/Cmdc.200800091 |
0.432 |
|
| 2007 |
Bagalkot V, Zhang L, Levy-Nissenbaum E, Jon S, Kantoff PW, Langer R, Farokhzad OC. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Letters. 7: 3065-70. PMID 17854227 DOI: 10.1021/Nl071546N |
0.488 |
|
| 2007 |
Zhang L, Radovic-Moreno AF, Alexis F, Gu FX, Basto PA, Bagalkot V, Jon S, Langer RS, Farokhzad OC. Co-delivery of hydrophobic and hydrophilic drugs from nanoparticle-aptamer bioconjugates. Chemmedchem. 2: 1268-71. PMID 17600796 DOI: 10.1002/Cmdc.200700121 |
0.481 |
|
| 2007 |
Bagalkot V, Farokhzad OC, Langer R, Jon S. Aptamer-dox conjugates as novel platform for targeted drug delivery and imaging Nanomedicine: Nanotechnology, Biology and Medicine. 3: 352. DOI: 10.1016/J.Nano.2007.10.070 |
0.548 |
|
| 2007 |
Wang A, Bagalkot V, Gu F, Alexis F, Vasilliou C, Cima M, Jon S, Farokhzad O. Novel Targeted Aptamer-superparamagnetic Iron Oxide Nanoparticle Bioconjugates for Combined Prostate Cancer Imaging and Therapy International Journal of Radiation Oncology*Biology*Physics. 69: S110-S111. DOI: 10.1016/J.Ijrobp.2007.07.203 |
0.415 |
|
| 2006 |
Bagalkot V, Farokhzad OC, Langer R, Jon S. An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angewandte Chemie (International Ed. in English). 45: 8149-52. PMID 17099918 DOI: 10.1002/Anie.200602251 |
0.556 |
|
| Show low-probability matches. |